Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Postgraduate Medical Journal|April 17, 2003
Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumoniaN Lubis, D Baylis, A Short, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
The prevalence and severity of intestinal disaccharidase deficiency in human immunodeficiency virus-infected subjectsC Taylor, K Hodgson, D Sharpstone, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2004
A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 countsL Waters, J Stebbing, R Jones, et al.
Postgraduate Medical Journal|December 1, 1988
Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central LondonR J Guiloff, G N Fuller, A Roberts, et al.
The American Journal of Physiology|June 11, 1999
The acute-phase protein response to human immunodeficiency virus infection in human subjectsF Jahoor, B Gazzard, G Phillips, et al.
HIV Medicine|April 19, 2003
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence resultsC Katlama, S Fenske, B Gazzard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppressionM Alfa-Wali, T Allen-Mersh, A Antoniou, et al.
HIV Medicine|June 13, 2002
Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapyJ Pido-Lopez, A Pires, M Nelson, et al.
The British Journal of Surgery|March 1, 1986
Clinical investigations of lymphadenopathy, including lymph node biopsies, in 24 homosexual men with antibodies to the human T-cell lymphotropic virus type III (HTLV-III)C F Farthing, K Henry, D C Shanson, et al.
Clinical and Experimental Immunology|October 23, 2002
Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infectionC T Burton, G A D Hardy, A K Sullivan, et al.
Pageof 19